MDB Capital Holdings Provides Second Quarter 2026 Update

Rhea-AI Summary

MDB Capital Holdings (NASDAQ: MDBH) reported operational highlights for the first six months of 2026, including serving as sole bookrunner and underwriter on the $20 million BUDA Juice IPO, joint bookrunner on the $15 million Ticketplus IPO, and completing a $5.9 million public offering for eXoZymes (NASDAQ: EXOZ).

MDB expanded its pipeline of early-stage disruptive companies, advanced discussions with potential MDB Direct/Public Ventures strategic partners, and prepared a spin-out of PatentVest as an independent public company. For the first half of 2026, MDB reported a net loss of approximately $16.1 million, fixed operating expenses of about $5 million, net cash used of about $3 million, and roughly $12.1 million in cash, current assets and marketable securities net of liabilities. Management will host a Zoom webinar on August 13, 2026, at 4:30 p.m. ET.

Positive

• $20 million BUDA Juice IPO as sole bookrunner and underwriter
• Joint bookrunner role on Ticketplus IPO of $15 million
• Completed $5.9 million public offering for eXoZymes
• Fixed operating expenses flat at approximately $5 million
• Net cash used limited to approximately $3 million in six months
• Cash, current assets and marketable securities net of liabilities about $12.1 million

Negative

• First half 2026 net loss of approximately $16.1 million
• Operating net loss, dilution and small impairment in eXoZymes about $4.4 million
• Non-cash loss on investment securities approximately $5 million
• Non-cash stock-based compensation expense booked at about $5 million

News Explained

The $5.9 million eXoZymes offering was described as completed underwriting by MDB, not an issuance by MDB; the release therefore establishes MDB’s transaction role but discloses no direct ownership change for MDB holders.

Market Context

SLNH fell 5.384615436196327% in the peer momentum data while MDBH reported its update. That comparis...

Analysis

SLNH fell 5.384615436196327% in the peer momentum data while MDBH reported its update. That comparison added market context; MDBH’s $12.1 million in cash, current assets, and securities remained a balance-sheet item to watch.

Key Figures

Buda Juice IPO: $20 million Ticketplus IPO: $15 million eXoZymes offering: $5.9 million +5 more

8 metrics

Buda Juice IPO $20 million First six months of 2026; MDB sole bookrunner and underwriter

Ticketplus IPO $15 million First six months of 2026; joint bookrunners

eXoZymes offering $5.9 million First six months of 2026; completed public offering underwriting

Net loss Approximately $16.1 million First six months of 2026

Operating net loss Approximately $4.4 million First six months of 2026; including dilution and eXoZymes impairment

Cash used Approximately $3 million First six months of 2026; net cash used

Cash and securities Approximately $12.1 million First six months of 2026; less all liabilities

Fixed operating expenses Approximately $5 million First six months of 2026; remained flat

Historical Context

5 past events · Latest: Jul 30 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 30	Update call announcement	Neutral	+0.7%	Scheduled a second-quarter operational update call and subsequent developments discussion.
Jul 23	PatentVest AI report	Neutral	+2.2%	Released analysis of OpenAI patent families, categories, ownership, and competitive positioning.
Jul 02	PatentVest AI article	Neutral	+0.0%	Published an article examining AI applications in patent prosecution and portfolio management.
Jun 30	PatentVest IP report	Neutral	+10.4%	Reported on FGF21, GLP-1 therapies, and related cardiometabolic intellectual-property activity.
Jun 15	Investor conference presentation	Neutral	+0.0%	Announced a Planet MicroCap presentation covering IP strategy and AI-native legal services.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent MDBH news events were followed by flat-to-positive price reactions, including gains of 2.24% and 10.41%.

Key Terms

bookrunner, underwriter, stock-based compensation, marketable securities

4 terms

bookrunner financial

"Completed $20 million IPO for Buda Juice as the sole bookrunner and underwriter"

A bookrunner is the lead bank or financial firm that organizes and manages a new securities offering, acting like a project manager who sets the price range, collects investor demand, and decides how shares are allocated. For investors, the bookrunner’s choices and reputation influence the final price, how many shares each buyer receives, and the overall chance the deal succeeds — similar to how a trusted referee shapes a fair and well-run auction.

underwriter financial

"as the sole bookrunner and underwriter, our 18th consecutive successful IPO"

An underwriter is a financial firm that evaluates, guarantees and helps sell a new security offering—such as a stock or bond—by buying the issue from the issuer and reselling it to investors or organizing the sale. Think of them as a bridge or safety net: they take on the risk, set the price, handle marketing and paperwork, and their work determines how much money a company can raise and how smoothly the offering reaches the market.

View in glossary

stock-based compensation financial

"Approximately $5 million in booked expense of non-cash stock-based compensation"

Stock-based compensation is when a company pays employees, directors or consultants with shares or the right to buy shares instead of or in addition to cash. It matters to investors because issuing stock or options spreads ownership thinner (like cutting a pie into more slices), which can reduce each existing share’s claim on profits and can also change reported earnings; investors watch it to assess true cost of running the business and how management is incentivized.

View in glossary

marketable securities financial

"Approximately $12.1 million held in cash, current assets, and marketable securities"

Marketable securities are financial assets — such as publicly traded stocks, bonds, and short-term government bills — that a company can quickly sell for cash at a known price. Investors watch them because they show how much ready cash a company can access without selling core operations, like keeping money in a highly liquid savings account versus being tied up in a house, and they affect short-term risk, financial flexibility, and balance-sheet strength.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Management to Host Conference Call Today at 4:30 p.m. ET

Addison, TX, Aug. 13, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-defining, disruptive technology companies, provides a business update for the quarter ended June 30, 2026, and subsequent developments.

First Six Months of 2026 and Subsequent Operational Highlights

• Completed $20 million IPO for Buda Juice (NYSE American: BUDA) as the sole bookrunner and underwriter, our 18^th consecutive successful IPO.

• Partnered with Roth Capital Partners and Bancroft Capital as joint bookrunners for the $15 million Ticketplus IPO (NYSE American; TP).
• Completed underwriting of $5.9 million public offering for eXoZymes (Nasdaq: EXOZ), advancing the AI-enabled cell-free biomanufacturing platform.
• Expanded our pipeline of early-stage, disruptive companies capable of becoming leaders in new categories.
• Advanced discussions with potential MDB Direct/Public Ventures strategic partners to significantly expand distribution of our offerings and monetize this valuable asset.
• Advanced preparations to spin-out PatentVest, our AI-Native IP law firm, to become an independent public company, further leveraging this unique asset to create value for MDB.
• Completed upgrade of MDB Direct clearing and trading platform to BetaNXT, a leading financial technology platform specializing in trading, settlement and wealth management, to deliver greater security, efficiency and future capabilities to our investors.
• Broadened relationships with Family Offices, RIAs and private wealth managers to reach new investors with large equity portfolios looking for new strategies to gain venture exposure.

First Six Months of 2026 Financial Results

• Reported a net loss of approximately $16.1 million of which:

• • Approximately $4.4 million in operating net loss, dilution and a small impairment in our equity investment in eXoZymes.
  • Approximately $5 million non-cash loss related to the value in investment securities held.
  • Approximately $5 million in booked expense of non-cash stock-based compensation valued in 2022.

• Fixed operating expenses remained flat at approximately $5 million, which includes approximately $2 million investment in MDB Direct/Public Ventures clearing platform and PatentVest subsidiaries.
• Net cash used of approximately $3 million.
• Approximately $12.1 million held in cash, current assets, and marketable securities less all liabilities.

Second Quarter 2026 Update Zoom Webinar at 4:30 p.m. ET Today

Christopher Marlett, CEO and Co-Founder of MDB will lead the call and may be joined by other members of the management team to review recent developments and ongoing initiatives as well as host a question-and-answer period.

Investors can pre-register now for the Zoom webinar HERE. The live webinar can also be accessed on the day of the event through MDB’s investor relations website at https://investors.mdb.com/ .

About MDB Capital Holdings, LLC

Every new category starts with a leader willing to build it and a story compelling enough for the market to believe. Since1997, MDB Capital has partnered with those founders, curating the breakthroughs, shaping the narrative, and launching them on the public markets before a traditional IPO would allow. Our public venture platform is purpose-built to enable breakthroughs reach the public markets and society sooner, and enable investors get in earlier on the companies defining what comes next — capturing asymmetric upside with public market liquidity. MDB Capital Holdings, LLC (NASDAQ: MDBH) and its subsidiaries—including MDB Capital, a venture-focused broker-dealer with the MDB Direct trading platform, and PatentVest, the first integrated IP strategy and law firm—operate under the MDB Capital brand. MDB Capital is a registered broker-dealer, Member FINRA/SIPC. For more information, please visit www.mdb.com.

Forward-Looking Statements

This press release contains "forward-looking statements." These forward-looking statements are made as of the date they were first issued and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as "expect," "anticipate," "should," "believe," "hope," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "might," "could," "intend," "shall" and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond MDB's control. MDB's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in documents that may be filed by MDB from time to time with the SEC. The forward-looking statements included in this press release represent MDB's views as of the date of this press release. MDB anticipates that subsequent events and developments will cause its views to change. MDB undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing MDB's views as of any date subsequent to the date of this press release.

Investor Relations Contact:
IR@mdb.com

Media Contact:
press@mdb.com

FAQ

What key capital markets transactions did MDB Capital Holdings (NASDAQ: MDBH) complete in early 2026?

MDB Capital completed a $20 million BUDA Juice IPO, a $15 million Ticketplus IPO as joint bookrunner, and a $5.9 million public offering for eXoZymes. According to MDB, these deals reflect its focus on disruptive, early-stage technology companies.

What was MDB Capital Holdings' net loss for the first six months of 2026 (MDBH)?

MDB Capital reported a net loss of approximately $16.1 million for the first six months of 2026. According to MDB, this includes about $4.4 million operating-related loss, $5 million non-cash loss on investment securities and $5 million non-cash stock-based compensation expense.

How much liquidity did MDB Capital Holdings report as of June 30, 2026?

MDB Capital reported approximately $12.1 million in cash, current assets and marketable securities less all liabilities. According to MDB, net cash used in the first six months of 2026 was about $3 million, indicating available resources to support its platform and subsidiaries.

What are MDB Capital Holdings' plans for PatentVest and MDB Direct/Public Ventures?

MDB Capital is preparing to spin out PatentVest as an independent public company and is advancing strategic partner discussions for MDB Direct/Public Ventures. According to MDB, these steps aim to expand distribution and further monetize its AI-native IP and distribution assets.

When is the MDB Capital Holdings Q2 2026 business update webinar and how can investors access it?

MDB Capital will host a Zoom webinar on August 13, 2026 at 4:30 p.m. ET. According to MDB, investors can pre-register online, and the live event will also be accessible through the company’s investor relations website at https://investors.mdb.com/.

How did MDB Capital Holdings manage operating expenses in the first half of 2026?

MDB Capital reported fixed operating expenses remained flat at approximately $5 million for the first six months of 2026. According to MDB, this figure includes around $2 million of investment in the MDB Direct/Public Ventures clearing platform and PatentVest subsidiaries.